Insights
Study Shows Peer Support Plus Telehealth Increases Success of Hepatitis C Treatment
A randomized controlled trial finds that pairing peer support with telemedicine significantly raises hepatitis C cure rates among people who use drugs, in work with OHSU and HIV Alliance.
January 22, 2025
Behavioral Health
The recently published paper “Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial” reveals that a combination of peer support and telemedicine can significantly boost the cure rate for hepatitis C.
Comagine Health, Oregon Health & Science University (OHSU), HIV Alliance and Bay Area First Step collaborated on the study to demonstrate a new approach to treating hepatitis C in rural Oregonians who use drugs. One group of study participants received information and referrals to local services from peers with lived experience in drug use. Participants in the other group received treatment with the new model, which included more intensive, ongoing peer support as well as telemedicine care from a team of health care providers.
Of those who were randomly placed in the intervention group, 63% were cured of hepatitis C, compared to just 16% of the participants in the other group.
Find out more about this exciting discovery:
- Peer-Assisted Telemedicine for Hepatitis C in People Who Use Drugs: A Randomized Controlled Trial (co-authored by Comagine Health Senior Director of Research and Evaluation Gillian Leichtling)
- Meeting People Where They Are: The Roles of Peer Navigation and Telemedicine for Hepatitis C Virus Elimination
- Telehealth Plus Local Peer Support Boosts Treatment Success for Hepatitis C in Rural Patients
- OHSU Study Shows How Peers With Lived Experience Can Help in Fight Against Hepatitis C
- OHSU Study Finds Secret to Curing Patients With Potentially Deadly Hepatitis C
Author / Contributor(s)
Recent Insights